Given the role of CD36 in enhancing ferroptosis through the transcriptional upregulation of CAV1 in TNBC, we further investigated the potential of ferroptosis activators to effectively inhibit TNBC tumor metastasis in the absence of CD36. This evidence concerns the gene CAV1 and neoplasm.